Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma

Figure 2

Steps of constructing the prognostic lncRNAs. (a) The differential analysis between glioma (including GBM and LGG patients) and normal brains. (b)-(c) Enrichment analysis of identified differentially expressed mRNA. (d) The lambda plot of necroptosis-related LncRNA by LASSO regression. (e) The LASSO coefficient profiles. (f) Forrest of 12 established LncRNA after multivariate Cox regression analysis.

(a)

(b)

(c)

(d)

(e)

(f)